Allendale biotechnology executive reaches $11M settlement with state for fraud – NorthJersey.com
By Dr. Matthew Watson
Allendale biotechnology executive reaches $11M settlement with state for fraud NorthJersey.com A former executive of three Allendale-based biotechnology companies has reached an $11 million settlement of a civil complaint with the New Jersey Division of Consumer Affairs' Bureau of Securities for defrauding investors, the state said Thursday. |
Uncategorized
Comments Off on Allendale biotechnology executive reaches $11M settlement with state for fraud – NorthJersey.com |
June 2nd, 2013
This author published 5872 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research